Showing results (421-430 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|April 28, 2022
Association of Quality-of-Life Outcomes in Cancer Drug Trials With Survival Outcomes and Drug ClassJoseph N Samuel, Christopher M Booth, Elizabeth Eisenhauer, et al.
JAMA Oncology|April 28, 2022
The Potential of the Gut Microbiome to Reshape the Cancer Therapy Paradigm: A ReviewLongsha Liu, Khalid Shah
JAMA Oncology|April 14, 2022
Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma: Results of the BONSAI Trial for the Italian Network for Research in Urologic-Oncology (Meet-URO 2 Study)Giuseppe Procopio, Pierangela Sepe, Melanie Claps, et al.
JAMA Oncology|March 25, 2021
Evolution of the Randomized Clinical Trial in the Era of Precision OncologyJoseph C Del Paggio, John S Berry, Wilma M Hopman, et al.
JAMA Oncology|March 4, 2021
Association of Breast Cancer Irradiation With Cardiac Toxic Effects: A Narrative ReviewIcro Meattini, Philip M Poortmans, Marianne Camille Aznar, et al.
JAMA Oncology|April 18, 2024
Adherence to American Cancer Society Nutrition and Physical Activity Guidelines Among Cancer SurvivorsCarter Baughman, Kathryn Norman, Kenneth Mukamal
JAMA Oncology|April 15, 2016
Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical TrialAhmad Awada, Ramon Colomer, Kenichi Inoue, et al.
JAMA Oncology|April 15, 2016
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent TumorsYuri E Nikiforov, Raja R Seethala, Giovanni Tallini, et al.
JAMA Oncology|June 28, 2016
Angiotensin II-Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer: A Randomized Clinical TrialAnnelies H Boekhout, Jourik A Gietema, Bojana Milojkovic Kerklaan, et al.
JAMA Oncology|September 18, 2015
Intermittent vs Continuous Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-analysisSindy Magnan, Ryan Zarychanski, Laurie Pilote, et al.
Pageof 161